Bruce D. Wyse
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
In vitro profiling of opioid ligands using the cAMP formation inhibition assay and the β-arrestin2 recruitment assay: No two ligands have the same profile.
Journal: European journal of pharmacology
Published: July 16, 2019
Nitric oxide modulates μ-opioid receptor function in vitro.
Journal: Clinical and experimental pharmacology & physiology
Published: December 05, 2018
The furoxan nitric oxide donor, PRG150, evokes dose-dependent analgesia in a rat model of painful diabetic neuropathy.
Journal: Clinical and experimental pharmacology & physiology
Published: April 18, 2015
Topical application of a novel oxycodone gel formulation (tocopheryl phosphate mixture) in a rat model of peripheral inflammatory pain produces localized pain relief without significant systemic exposure.
Journal: Journal of pharmaceutical sciences
Published: March 06, 2015
Optimization and pharmacological characterization of a refined cisplatin-induced rat model of peripheral neuropathic pain.
Journal: Behavioural pharmacology
Published: October 18, 2014
Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathy.
Journal: Behavioural pharmacology
Published: February 15, 2014
Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain.
Journal: Pain medicine (Malden, Mass.)
Published: January 18, 2014
Endomorphin analogues with mixed μ-opioid (MOP) receptor agonism/δ-opioid (DOP) receptor antagonism and lacking β-arrestin2 recruitment activity.
Journal: Bioorganic & medicinal chemistry
Published: December 05, 2013
In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.
Journal: British journal of pharmacology
Published: November 01, 2013
A small molecule angiotensin II type 2 receptor (AT₂R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia.
Journal: Pain medicine (Malden, Mass.)
Published: June 08, 2013
Small molecule angiotensin II type 2 receptor (AT₂R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats.
Journal: Pain medicine (Malden, Mass.)
Published: March 16, 2013
Last Updated: 09/26/2026